Dietmar

ElectraMeccanica Reports AGM Results

Retrieved on: 
Monday, August 1, 2022
Alternative Energy, Energy, EV, Electric Vehicles, Automotive, Celebrity board director, LLP, Original equipment manufacturer, Sale, KPMG LLP, KPMG, Chartered Professional Accountant, Sustainability Accounting Standards Board, U.S. Securities and Exchange Commission, OEM, Regulation, Forward-looking statement, Temperature, SEC, EV, Ostermann, BMW, Air conditioning, Kearney (consulting firm), Phrase, EVS, Board, Safety, NASDAQ, News, AGM, Partnership, SEDAR, PricewaterhouseCoopers, Mission statement, Company, SOLO, Dietmar, MSRP, Compensation, Audit, Engineering, Risk, Motor vehicle, Management, Director

ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) (ElectraMeccanica or the Company) is pleased to announce the results of the Companys annual general meeting (the AGM) held on July 27, 2022.

Key Points: 
  • ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) (ElectraMeccanica or the Company) is pleased to announce the results of the Companys annual general meeting (the AGM) held on July 27, 2022.
  • At the AGM, the Board of Directors (the Board) reviewed and approved its fiscal 2021 results and information circular and proxy statement, which can be accessed on SEDAR ( www.sedar.com ) and which provides additional detail on the Company, its operations and governance.
  • ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) is a Canadian designer and manufacturer of environmentally efficient electric vehicles (EVs).
  • These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

DGAP-News: Baader Bank appoints Dietmar von Blücher as General Manager (Generalbevollmächtigter)

Retrieved on: 
Wednesday, November 18, 2020
Baader, Dietmar, Baade

Unterschleissheim, 18/11/2020: The Baader Bank management team will be strengthened from 1 January 2021 as the bank appoints Dietmar von Blcher as its General Manager (Generalbevollmchtigter).

Key Points: 
  • Unterschleissheim, 18/11/2020: The Baader Bank management team will be strengthened from 1 January 2021 as the bank appoints Dietmar von Blcher as its General Manager (Generalbevollmchtigter).
  • Mr von Blcher will help to organise Baader Bank in his role as General Manager from the start of next year.
  • By appointing Mr von Blcher, Baader Bank is ensuring a smooth transition into the CFO succession process.
  • "In Dietmar von Blcher, Baader Bank has secured the services of an outstanding industry expert and a proven financial specialist.

Hyloris appoints Dr. Dietmar Aichhorn as Chief Operating Officer

Retrieved on: 
Thursday, October 1, 2020
Aichhorn, Dietmar

Dr. Dietmar Aichhorn, PhD, is a chemical engineer with over 20 years of experience in the pharmaceutical industry.

Key Points: 
  • Dr. Dietmar Aichhorn, PhD, is a chemical engineer with over 20 years of experience in the pharmaceutical industry.
  • Dr. Dietmar Aichhorn is an expert in the fields of technical development, clinical development and regulatory affairs in the US, EU and other key geographies.
  • In this newly created role, Dr. Dietmar Aichhorn will be responsible for leading the development of Hyloris growing product portfolio.
  • Stijn Van Rompay, Chief Executive Officer and co-founder of Hyloris, commented: "We are pleased to welcome Dietmar to our management team.

DGAP-News: German Federal Government invests 300 Million Euros in CureVac

Retrieved on: 
Monday, June 15, 2020
States of Germany, Companies, CureVac, Government of Germany, Dietmar Hopp, Walldorf, KfW, SAP SE, Hopp, Peter Altmaier, Dietmar, dievini, CureVac AG

- mRNA company CureVac retains complete operational and strategic independence; the Federal Government will not influence corporate policy decisions

Key Points: 
  • - mRNA company CureVac retains complete operational and strategic independence; the Federal Government will not influence corporate policy decisions
    BERLIN/WALLDORF, Germany - 15 June 2020 - The German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp, SAP co-founder and co-founder of the investment company dievini Hopp BioTech holding GmbH & Co. KG, announced today that the Federal Republic of Germany will invest 300 million Euros in the biopharmaceutical company CureVac AG, a pioneer in the preclinical and clinical development of mRNA-based drugs.
  • Under the agreement, the KfW will hold a stake of around 23 percent in CureVac.
  • The German Federal government has decided to invest in this promising company because it expects that this will accelerate the development programs and provide the means for CureVac to harness the full potential of its technology.
  • CureVac is just one of the early and outstanding examples of visionary entrepreneurial biotech innovation from Germany.

Dietmar Siemssen Appointed New CEO of Gerresheimer AG

Retrieved on: 
Thursday, September 6, 2018
Gerresheimer, Dietmar

"By bringing Dietmar Siemssen on board, we have gained a seasoned manager with international experience to lead Gerresheimer AG for some time to come.

Key Points: 
  • "By bringing Dietmar Siemssen on board, we have gained a seasoned manager with international experience to lead Gerresheimer AG for some time to come.
  • I am confident that, under his leadership, Gerresheimer will continue on its current growth trajectory and effectively execute the strategic expansion plans underway," explains Dr. Axel Herberg, Chairman of the Supervisory Board of Gerresheimer AG.
  • I am very optimistic as I look ahead to this exciting new mission," adds Dietmar Siemssen.
  • Dietmar Siemssen joined international automotive supplier Stabilus as CEO in 2011.